Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors. [electronic resource]
Producer: 20160303Description: 1299-307 p. digitalISSN:- 1523-6536
- Acute Disease
- Adult
- Chronic Disease
- Cyclophosphamide -- therapeutic use
- Female
- Graft vs Host Disease -- etiology
- Haplotypes
- Hematologic Neoplasms -- immunology
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Histocompatibility Testing
- Humans
- Immunosuppressive Agents -- therapeutic use
- Male
- Middle Aged
- Mycophenolic Acid -- analogs & derivatives
- Myeloablative Agonists -- therapeutic use
- Prospective Studies
- Recurrence
- Risk
- Survival Analysis
- Tacrolimus -- therapeutic use
- Transplantation Conditioning
- Transplantation, Isogeneic
- Unrelated Donors
- Whole-Body Irradiation
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.